Plasmids encoding``split'' lactose permease constructs with discontinuities in either the periplasmic loop between helices V and VI (N 5 /C 7 ) or between helices VI and VII (N 6 /C 6 ) were used to localize helix VI within the tertiary structure by site-directed thiol cross-linking. A total of 57 double-Cys pairs, with one Cys residue in helix VI and another in helix V or VIII, were studied with homobifunctional cross-linking agents. Signi®cant cross-linking is observed between the periplasmic ends of helices V (position 158 or 161) and VI (position 170) with rigid 6 or 10 A Ê reagents. Furthermore, the Cys residue at position 170 (helix VI) also cross-links to a Cys residue at either position 264 or 265 (helix VIII) with a 21 A Ê cross-linking agent. The data indicate that helices V, VI and VIII are in close proximity at the periplasmic face of the membrane, with helix VI signi®cantly closer to helix V. In addition, b,D-galactopyranosyl 1-thio-b,D-galactopyranoside induces a signi®cant increase in cross-linking ef®ciency between helices VI and VIII and between helices V and VIII, with no signi®cant change in cross-linking between helices V and VI.
Introduction
The lactose permease of Escherichia coli (LacY) 1 is a paradigm for membrane transport proteins that couple free energy stored in an electrochemical ion gradient into a solute concentration gradient. 1 ± 4 Thus, LacY catalyzes the coupled stoichiometric translocation of galactosides and H (lactose/H symport). The protein has been solubilized from the membrane, puri®ed in a completely functional state (reviewed by Viitanen et al.
5
) and shown to function as a monomer. 6 LacY has 12 transmembrane helices with the N and C termini on the cytoplasmic face of the membrane. 7 ± 9 To obtain any insight whatsoever into the molecular mechanism of transport, it is essential to determine helix packing, identify the residues that are critical for the mechanism and determine their relationship to one another, as well as their functional role in the mechanism.
In a functional LacY mutant devoid of native Cys residues, each residue has been replaced with Cys or other residues (reviewed by Frillingos et al. 10 ). Analysis of the single-Cys mutant library and other site-directed mutants utilizing a variety of site-directed biophysical and biochemical techniques has led to the following developments (reviewed by Frillingos et al. 10 and Kaback & Wu 11 ): (i) The great majority of the mutants are expressed normally in the membrane and exhibit signi®cant transport activity, and only six sidechains are clearly irreplaceable with respect to active transport: Glu126 (helix IV) and Arg144 (helix V), which are essential for ligand binding, and Glu269 (helix VIII), Arg302 (helix IX), His322 (helix X) and Glu325 (helix X), which are critical for H translocation and coupling.
(ii) Helix packing, tilts and ligand-induced conformational E-mail address of the corresponding author: RonaldK@HHMI.UCLA.edu Abbreviations used: LacY, lactose permease; Cys-less LacY, functional lactose permease devoid of Cys residues; N 5 /C 7 , permease expressed as nonoverlapping fragments with a discontinuity in the periplasmic loop V and VI; N 6 , six N-terminal transmembrane helices; C 6 , six C-terminal transmembrane helices; TDG, b,D-galactopyranosyl 1-thio-b,D-galactopyranoside; NEM, N-ethylmaleimide; o-PDM, o-phenylenedimaleimide; p-PDM, pphenylenedimaleimide; BMH, 1,6-bis(maleimido)hexane; MTS-1-MTS, 1,1-methanediyl bismethanethiosulfonate; MTS-8-O2-MTS, 3,6-dioxaoctane-1,8-diyl bismethanethiosulfonate; MTS-14-O4-MTS, 3,6,9,12-tetraoxatetradecane-1,14-deiyl bismethanethiosulfonate; MTS-17-O5-MTS, 3,6,9,12,15-pentaoxaheptadecane-1,17-diyl bismethanethiosulfonate; KP i , potassium phosphate. changes have been determined. (iii) Positions that are accessible to solvent have been revealed. 12 ± 14 (iv) Positions where the reactivity of the Cys replacement is increased or decreased by ligand binding have been identi®ed. (v) The permease has been shown to be a highly¯exible molecule. (vi) A working model describing a mechanism for lactose and H symport has been formulated. 15 Although at least some data regarding the position of most of the helices within the tertiary structure of LacY are available, 11 no information has been obtained for helix VI. In this study, we use site-directed thiol cross-linking in situ, a powerful approach for estimating helix packing, tilts, and ligand-induced conformational changes, to localize this transmembrane domain. In addition, a ligandinduced change in distance between the periplasmic ends of helices VI and VIII is documented.
Results

Mutant construction and transport activity
A plasmid encoding contiguous, non-overlapping lactose permease fragments with a discontinuity in the periplasmic loop between helices V and VI was constructed (split N 5 /C 7 , where N x indicates the x N-terminal transmembrane helices, and C x indicates x C-terminal transmembrane helices) to investigate the physical relationship between helices V and VI. N 5 /C 7 LacY transports lactose at better than 50 % the rate of intact Cys-less LacY to a similar steady-state level of accumulation ( Figure 1 ) and is expressed well in the membrane, as judged by Western blots with anti-C-terminal antibody (data not shown). Thirtyseven paired-Cys mutants with one Cys residue in helix V and another in helix VI were constructed by PCR using the DNA encoding N 5 /C 7 Cys-less lacY as template. Mutants V158C/F170C and M161C/F170C, which are shown to exhibit crosslinking, are somewhat less active but accumulate lactose to steady-states of 50 % and 60 % of Cys-less LacY, respectively.
Cross-linking between helices V and VI
Cross-linking of the 37 paired-Cys mutants was studied in situ by using various homobifunctional cross-linking agents or oxidants, followed by SDS-PAGE and immunoblotting with site-directed polyclonal antibody against the C terminus of LacY. 16 The C 7 fragment electrophoreses with an M r of about 21 kDa, while cross-linked product migrates at about 32 kDa, the same position as Cys-less LacY (Figure 2(a) ). Nine paired-Cys mutants did not express suf®ciently well to evaluate cross-linking (see the legend to Figure 3(a) ).
When membranes containing LacY with paired Cys residues in place of Val158 and Phe170, which are at the periplasmic ends of helices V and VI, respectively (Figure 3 C, ef®cient cross-linking is clearly observed relative to the non-treated control sample (Figure 2(a) ). Similarly, the Cys at position 170 cross-links ef®ciently to a Cys residue in place of Met161, which is presumably one turn removed from position 158 on the same face of helix V (Figure 2(b) ). With both pairs, cross-linking was measured at 5, 30 and 60 minutes, and strong cross-linking is observed by 30 minutes with maximum labeling at 60 minutes. When the reactions are carried out at 0 C, cross-linking is also obtained, but the rate is decreased, indicating that protein thermal motion is important for ef®cient cross-linking (data not shown). In addition, the Cys residue at position 170 also cross-links weakly to a Cys residue at position 157 in helix V in the presence of o-PDM. No signi®cant cross-linking between Cys residues at positions 158 and 170 or positions 161 and 170 is observed with iodine, diamide or the shorter cross-linking agent 1,1-methanediyl bismethanethiosulfonate (MTS-1-MTS; 3 A Ê ), and no cross-linking is observed between Cys residues at positions 170 and 159 or 160 in the presence of o-PDM. Thus, in addition to demonstrating that helices V and VI are in close proximity at their periplasmic ends, the data are consistent with helical structure at the periplasmic end of helix V (Figure 3 cross-linking is observed with homobifuntional cross-linking agents in which the distance between the functional groups ranges from 3 A Ê to 21 A Ê (see Figure 3 (a)).
Cross-linking between helices VI and VIII
Since helix VI appears to be close to helix V, and helix V is in close proximity to helix VIII, as judged by site-directed chemical cleavage, 18 chemical cross-linking 19, 20 and site-directed spin labeling, 19, 21 helix VI might also be close to helix VIII. In order to test this possibility, 20 paired Cys mutants were constructed in plasmids pN 6 and pC 6 , which encode six N-terminal transmembrane helices (N 6 ) containing a biotin acceptor domain 20 and six C-terminal transmembrane helices (C 6 ) portions of LacY, each with a given single Cys residue in helix VI and VIII, respectively, and cross-linking was carried out in situ. Five paired-Cys mutants are expressed poorly (see the legend to Figure 3 Figure 5(b) ). In addition, no signi®cant change is observed with shorter cross-linking agents.
Since a previous study 20 of cross-linking between helices V and VIII did not test the effect of ligand, the effect of TDG on cross-linking with V158C (helix V)/T265C (helix VIII) LacY was investigated here ( Figure 6 ). As shown, this paired-Cys mutant exhibits signi®cant TDG-induced increases in cross-linking ef®ciency with each homobifunctional cross-linking agent tested, with o-PDM exhibiting the most pronounced effect (Figure 6 ). On the other hand, paired-Cys mutants 158/170 or 161/ 170 in helices V and VI, respectively, exhibit no sig- (Figure 7(a) ). The effect of o-PDM on transport was studied under the same conditions as those used for cross-linking (Figure 7(b) ). Although both paired-Cys mutants cross-link with very high ef®ciency in the presence of o-PDM, transport is inhibited by only 30-40 %, suggesting that there is little movement at the interface between helices V and VI during turnover of the permease.
Discussion
Site-directed thiol cross-linking in situ with split LacY constructs or mutants with an engineered protease site is a powerful approach to estimate helix packing and to probe ligand-induced conformational changes (reviewed by Kaback & Wu 11 ). Here, the approach is applied to helix VI, the only remaining transmembrane domain in LacY for which no data is available regarding localization within the tertiary structure. With paired Cys residues throughout helices V and VI of N 5 /C 7 split LacY, cross-linking is observed only between positions 158 or 161 (helix V) and 170 (helix VI) with o-PDM and p-PDM, indicating that the periplasmic ends of the two helices are within reasonably close proximity. However, no cross-linking is observed 28 Arg144 and Glu269 are enlarged to indicate that they are irreplaceable residues. Although not highlighted, mutants F170C, G173C, and A187C are sensitive to inhibition by NEM, and replacement of Ala177 or Leu184 with Cys results in low activity in the Cys-less background. 22 with paired Cys residues in either the middle or cytoplasmic regions. Thus, helices V and VI probably tilt away from each other towards the cytoplasmic face of the membrane. However, poor expression of certain paired-Cys mutants in these regions may weaken this conclusion to some extent. Also, the lack of cross-linking detected in these regions may be due to poor accessibility and/or low reactivity of these Cys residues to the cross-linking reagents used.
Cys-scanning mutagenesis of helix VI 22 reveals that Cys replacements at most positions do not inactivate transport. Mutants A177C and L184C exhibit low activity (ca 20 %) in the Cys-less background, but signi®cantly higher activity (60-70 %) in the wild-type. Moreover, N-ethylmaleimide (NEM) inactivates transport with mutants F170C, G173C and A187C. On the basis of the observation that the mutation A177V alters sugar speci®city, it was suggested that Ala177 is involved in substrate recognition. 23 ± 25 As discussed by King & Wilson, 24 ,26 a direct role seems unlikely, since neither Ala nor Val can H-bond to sugars or bind H , while replacement of Ala177 with Val has pleiotropic effects, altering speci®city for many sugars and modifying coupling between lactose and H translocation. It is also noteworthy in this regard that TDG does not change the reactivity of A177C LacY with NEM or 7-(diethylamino)-3-(4 Hmaleimidylphenyl)-4-methylcoumarin. 22 As indicated by the ®ndings that a Cys residue at position 170 (helix VI) cross-links with Cys residues at either position 158 or 161 (helix V), Ala177 and the other residues in helix VI that appear to be of any importance lie on the face of helix VI that abuts helix V (Figure 3(b) ). Therefore, it seems reasonable to suggest that the functional effects of mutations or other perturbations on this face of helix VI result from relatively subtle structural alterations in helix V, which contains Arg144 and Cys148, two residues that are involved directly in substrate binding.
11
Studies with N 6 C 6 split LacY with paired-Cys residues in helices VI and VIII demonstrate that a Cys residue in place of Phe170 (helix VI) also cross-links with a Cys residue in place of either Val264 or Thr265 (helix VIII), but only with MTS-17-O5-MTS, a rigid homobifunctional cross-linking agent 21 A Ê in length. Thus, although the periplasmic end of helix VI is in the vicinity of helix VIII, it is signi®cantly closer to helix V (Figure 3(b) ). As with helices VI and V, no cross-linking is observed Figure 5 . Effect of ligand on the cross-linking between helices VI and VIII. Cross-linking was carried out in situ with a given cross-linking agent at 24 C for one hour in the absence or presence of 10 mM TDG added prior to initiating the cross-linking reaction. Immunoblots were probed with site-directed polyclonal antibody against the C terminus of LacY as described in Cross-linking with a given cross-linking agent was carried out in situ at 24 C for one hour, and immunoblots were probed with site-directed polyclonal antibody against the C terminus of LacY as described in Materials and Methods. The C 6 fragment migrates at about 20 kDa, and cross-linked N 6 /C 6 with the biotin acceptor domain migrates at about 46 kDa.
Location of Helix VI in LacY
between paired-Cys residues in either the middle or the cytoplasmic regions of helices VI and VIII. In view of these observations and cross-linking data indicating that abutting faces of helices V and VIII cross-link throughout the thickness of the membrane, 20 it would appear that the periplasmic ends of helices V, VI and VIII are in relatively close proximity, with helix VI near helices V and VIII, but closer to helix V (Figure 3(b) ). Moreover, while helices V and VIII remain in close proximity as they traverse the membrane, helix VI probably tilts away from helices V and VIII towards the cytoplasmic face of the membrane, either approximating another transmembrane helix or becoming embedded in the interior of the bilayer. Such an interpretation is consistent with recent studies utilizing single amino acid deletion analysis, 27 which indicate that helix VI makes few mechanistically important helix-helix contacts.
Ligand binding markedly increases NEM labeling of a Cys residue at position 265 and causes this position to become accessible to solvent, but decreases the reactivity of a Cys at position 264. 28 Interestingly, TDG dramatically enhances crosslinking ef®ciency between position 170 (helix VI) and position 265 or 264 (helix VIII), indicating that the periplasmic ends of these helices become more closely approximated in the presence of ligand. Moreover, ligand-binding dramatically increases cross-linking ef®ciency between Cys residues at position 158 (helix V) and 265 (helix VIII), but no signi®cant effect is observed between positions 170 (helix VI) and 158 or 161 (helix V). Taken together, the data suggest that the periplasmic end of helix VIII more closely approximates both helices VI and V in the presence of ligand. This conclusion is particularly noteworthy, since: (i) it has been shown that helix V contains Arg144, which is irreplaceable; 29 ± 32 (ii) that Glu269 (helix VIII) plays an important role in stabilizing the protonated, outwardly facing, high-af®nity conformation of LacY; and (iii) that changes in interaction between Glu269 and His322 (helix X) are probably critical for turnover. 15, 33 On the other hand, conformational changes between helices V and VI do not appear to play an essential role in turnover, since high-ef®-ciency cross-linking between Cys residues at the periplasmic ends of these helices has a relatively small effect on transport activity.
Materials and Methods
Construction of N 5 /C 7 Cys-less LacY with paired-Cys residues Inverse PCR was used to create N 5 /C 7 Cys-less LacY by inserting a 22 bp fragment (TAAGAATTCAGGAGG-TATTATG) containing a stop codon, an EcoRI restriction site, a Shine-Dalgarno sequence and an initiation codon between positions Ile164 and Asn165 (periplasmic loop V/VI) in plasmid pT7-5 containing cassette Cys-less lacY. 34 The N 5 fragment encodes residues 1-164 and C 7 fragment encodes residues 165-417. A total of 37 pairedCys mutants in the N 5 /C 7 Cys-less LacY background, with one Cys residue in helix V and another in helix VI, were constructed by using three-step PCR with pT7-5/ N 5 C 7 Cys-less lacY as template. All constructions were veri®ed by DNA sequencing. 35 Construction of N 6 /C 6 , LacY with paired-Cys residues Plasmids pN 6 and pC 6 , which encode the N-terminal half of Cys-less LacY, with a 100 residue biotin acceptor domain at the C terminus and the C-terminal half of Cys-less LacY, respectively, have been described. 36 Construction of lacY mutants containing single-Cys replacements in helices VI and VIII have been described. 22, 37 To introduce a Cys residue at position 170, 171, 173, 174, 177, 180, 181, 182 or 184 of helix VI into Cys-less N 6 , the BstBI-XhoI fragment of plasmid pN 6 was replaced with the corresponding DNA fragment containing a Cys codon in a given position from pT7-5/cassette lacY encoding the single Cys residue. Mutants containing a single Cys residue at position 261, 265, 267, 272, 275, 278 or 279 of helix VIII in the Cys-less pC 6 background have been described. 20 Single-Cys mutants at position 264, 271 Figure 6 . Effect of ligand on the cross-linking between helices V and VIII. Cross-linking was carried out in situ with a given crosslinking agent at 24 C for one hour in the absence or presence of 10 mM TDG added prior to initiating the crosslinking reaction. Immunoblots were probed with site-directed polyclonal antibody against the C terminus of LacY as described in Materials and Methods. The C 6 fragment is about 20 kDa and cross-linked N 6 /C 6 with the biotin acceptor domain migrates at about 46 kDa. or 274 were constructed by PCR mutagenesis. All constructs were veri®ed by DNA sequencing. 35 Expression of split LacY and membrane preparation
)) was transformed with plasmids encoding N 5 C 7 lacY with given mutations or co-transformed with both pN 6 and pC 6 , encoding the N and C-terminal halves of LacY with a given single Cys residue in helices VI and VIII, respectively. Cells transformed with given plasmids were grown at 37 C in Luria-Bertani broth (100 ml) containing ampicillin (100 mg/ml; pN 5 C 7 ) or ampicillin and chloramphenicol (100 mg/ml and 25 mg/ml, respectively; pN 6 and pC 6 ) and induced with 1 mM isopropyl 1-thio-b,D-galactopyranoside (IPTG) for two hours. Cells were harvested, washed with 20 mM Tris-HCl (pH 7.4)/2.0 mM EDTA, suspended in the same buffer and disrupted by soni®-cation, followed by centrifugation at 20,000 g for 15 minutes to remove the unbroken cells. Membranes were then harvested from the supernatant by ultracentrifugation at 440,000 g for ten minutes at 4 C. The supernatant was discarded, and the pellet was suspended in 20 mM Tris-HCl (pH 7.4) at a concentration of about 2 mg/ml.
Cross-linking
Unless stated otherwise, cross-linking reactions were carried out at 24 C for one hour in the presence of iodine or diamide at ®nal concentrations of 2.5 mM or 10 mM, respectively. The following thiol-speci®c homobifunctional cross-linking agents were used: o-PDM (6 A Ê ; rigid), p-PMD (10 A Ê ; rigid) or BMH (16 A Ê ) at a ®nal concentration of 0.5 mM; MTS-1-MTS (3 A Ê ), MTS-8-O2-MTS (11 A Ê ), MTS-14-O4-MTS (16 A Ê ) or MTS-17-O5-MTS (21 A Ê ) at a ®nal concentration of 0.05 mM. When iodine, diamide or homobifunctional MTS cross-linkers were used, the reactions were terminated by addition of 5 mM NEM. With homobifunctional maleimide cross-linkers, reactions were terminated by addition of 10 mM dithiothreitol (DTT). Samples were subjected to SDS-PAGE (12 % (w/v) polyacrylamide) and immunoblotting with a site-directed polyclonal antibody against the C terminus of LacY. 16 In vivo cross-linking was carried out in EDTA-treated cells (C.D. Wolin & H.R.K., unpublished results). After quenching the reactions with 10 mM DTT, cells were washed with 100 mM KP i (pH 7.5), 10 mM MgSO 4 and resuspended in the same solution to a concentration of 0.7 mg protein/ml. One portion of cells was assayed for transport activity in the presence of 0.2 mM phenazine methosulfate and 20 mM ascorbic acid under oxygen 38 with [1- 14 C]lactose (2.5 mCi/mmol) at a ®nal concentration of 0.4 mM; the remainder was used to prepare membranes that were subjected to immunoblotting in order to measure cross-linking.
Transport assays
Active lactose transport by intact E. coli T184 was measured as described 39 using [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]lactose (2.5 mCi/ mmol; ®nal concentration 0.4 mM) and rapid ®ltration.
